Smart ring maker Oura and glucose monitoring giant Dexcom just struck a partnership that will allow the company's products to ...

The two companies will launch integrations enabling data to flow between Dexcom products, including glucose biosensors and ...

DexCom (NASDAQ:DXCM) is investing $75M in Finnish health tech firm ŌURA as part of the latter’s Series D funding round. ŌURA, ...

"Partnering with OURA gives us the opportunity to redefine the category again, integrating data from Dexcom glucose ...

Smart ring maker Oura Health Oy is getting a $75 million investment from medical device firm Dexcom Inc., setting the stage for the two companies to share data and cross-sell products.

This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging ...

Additionally, the economic cycle might have an impact, and people are buying less products in times of economic distress. However, in case of Dexcom, another reason seems to be extremely important ...

DexCom said its revenue amounted to $994 million for the period. This was, however, only 2% higher on a year-over-year basis for the previously fast-growing glucose monitoring products specialist.

and ensure that its products are well-aligned with patient needs and market demands. During Q3, DexCom focused on product innovation and market expansion. The launch of the Stelo biosensor marked ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

products, operating plans and performance. All forward-looking statements included on this call are made as of the date hereof based on information currently available to Dexcom, are subject to ...